This webinar will be on the:

  • • Development of SARS-CoV-2 animal model
  • • SARS-CoV-2 vaccine: platform development and characterization
  • • SARS-CoV-2 preclinical safety and efficacy studies
  • • Isolation and characterization of SARS-CoV-2 neutralizing antibodies

Moderator

Prof. Joseph G. Schenker

President of International Academy of Human Reproduction. Professor of Obstetrics and Gynecology at The Hebrew University of Jerusalem.
Chairman of the Department of Obstetrics and Gynecology (Emeritus), Hadassah-University Hospital, Jerusalem. His research has involved experimental and clinical studies in the endocrinology of human reproduction, development of methods for contraception, and development of technologies in practice of assisted reproduction. He is interested in the ethical aspects of reproduction and gynecological and obstetric practice, and has chaired the Ethical Committee of IFFS and the FIGO Committee for the Study
of Ethical Aspects on Human Reproduction He has produced publications in medical journals and several books in the field of obstetrics & gynecology and reproduction.


Panelist

Dr. Nir Paran PhD
Tenure researcher and head of virology section, Department of Infectious Diseases, Israel Institute for Biological Research

Education 
1991-1994 -BSc. With honors (Cum Laude) in Life sciences, the Hebrew University, Jerusalem,
1994-1997- MSc. Dep Of Molecular Genetics, the Weizmann Institute of Science, Rehovot, Israel.
1997-2002- PhD. Dep. Of Molecular Genetics, the Weizmann Institute of Science, Rehovot, Israel.
 
Research appointments
 2002-present– Tenure researcher, Department of Infectious Diseases, Israel Institute for Biological Research, Ness Ziona, Israel.
2008-2009- Adjunct investigator during sabbatical at the laboratory of prof. Bernard, Moss, GES ,LVD, NIAID, NIH, USA
2011-2017- Head of a virology research group, Israel Institute for Biological Research,
Ness Ziona
2017-present Head of a virology section, Israel Institute for Biological Research, Ness Ziona


Panelist

Dr. Tomer Israely PhD
Tenure senior researcher in the virology research group at the Department of Infectious Diseases, Israel Institute for Biological Research. Since 01/2019 P.I. of the virology group of IIBR

Ph.D. Feinberg Graduate School of the Weizmann Institute of Science, Rehovot, Israel. Department of Biological Regulation.
Ph.D. Thesis: “Angiogenesis in ectopic ovary transplantation”.
M.Sc. Tel Aviv University, Tel Aviv, Israel. The Department of Molecular Microbiology and Biotechnology.
B.Sc. Tel-Hai Academic College, The Department of Biotechnology and Environmental Science, Tel-Hai, Israel. Average: With honors.

 

The Israel Institute for Biological Research (IIBR) is a governmental, cutting-edge applicable research institute, specializing in the fields of biology, chemistry and environmental sciences.The capabilities, scientific achievements and international reputation of IIBR are a result of decades of research and development (R&D) aimed at defense from chemical and biological threats. IIBR’s core activities have generated leading capabilities in: biochemical processes, genomics, proteomics, pathophysiology of various infectious diseases and chemical exposures, pharmacology, synthesis of small and large molecules, bioinformatics, mathematical models, remote sensing, monitoring, advanced chemical analysis, diagnostic microbiology, environmental safety and more.IIBR recruits leading Israeli scientists and support staff and benefits from facilities built to serve the topmost research and strict safety standards. IIBR regularly updates scientific technologies and infrastructure.IIBR works in compliance with Good Manufacturing Practice (GMP) and the ISO9001 and 14001 standards.Prominent R&D, service culture, scientific innovation and strict compliance with project work plans synergistically lead to breakthroughs and achievements.Numerous publications in leading journals, patents, prestigious grants, prizes, innovation of an ethical drug for Sjogren Syndrome and molecules with therapeutic potential all lead to national and international recognition and collaborations.

Starting with the 1974 Congress in Rio de Janeiro,
the Academy encourages the exchange of clinical experience and promote scientific thought and investigation.
Its events are designed to promote excellence in reproduction and aim to bridge gaps between the expansion of information and its implementation in clinical practice.